Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions

The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1##

wherein the variables A, B, Y, D, Z¹, G and e are as described herein.